Article information
Full text is only aviable in PDF
Bibliografía
[1.]
F. Antoñanzas, F. Antón, C. Juarez.
Cálculo de los costes de sida en España mediante técnicas de simulación.
Med Clin (Barc), 104 (1995), pp. 568-572
[2.]
C. Alvarez-Dardet.
Hernandez-Aguado. AIDS in Spain: lessons from a public health disaster.
J Epidemiol Community Health, 48 (1994), pp. 331-332
[4.]
L. De la Fuente Hoz, G. Barrio Anta.
Control de los problemas de salud asociados al consumo de drogas en España: hacia un abordaje científico y priorizado.
Gac Sanit, 10 (1996), pp. 255-260
[6.]
R. Manzanera, L. Torralba, M.T. Brugal, R. Armengol, P. Solanes, J.R. Villalbí.
Afrontar los estragos de la heroína: evaluación de diez años de un programa integral.
Gac Sanit, 14 (2000), pp. 58-66
[7.]
N. Krieger, S. Zierler.
The need for epidemiology theory.
Epidemiology, 8 (1997), pp. 212-213
[8.]
Van Ameijden EJC.
Evaluation of AIDS-prevention measures among drug users: the Amsterdam experience.
Ponsen Looijen BV, (1994),
[9.]
J.E. Fielding.
Public Health in the twentieth century: advances and changeless.
Annu Rev Public Health, 20 (1999), pp. 13-30
[10.]
R. Bayer.
Science, politics and AIDS prevention policy.
J Acquir Immune Defic Syndr Hum Retrovirol, 14 (1997), pp. S22-S29
[11.]
M.V. Zunzunegi.
¿Es la prescripción médica de heroína una opción de tratamiento para la adicción a la heroína.
Med Clin (Barc), 113 (1999), pp. 219-221
[12.]
M. Rebagliato, M.J. Aviñó, I. Hernandez-Aguado, et al.
Trends in incidence and prevalence of HIV-1 infection in intravenous drug users in Valencia, Spain.
J Acquir Immune Defic Syndr, 8 (1995), pp. 297-301
[13.]
I. Hernandez-Aguado, M.J. Aviño, S. Perez-Hoyos, et al.
Human immunodeficiency virus (HIV) infection in parental drug users: evolution of the epidemic over 10 years.
Int J Epidemiol, 28 (1999), pp. 335-340
[14.]
E.J.C. Van Ameijden, J.A.R. van den Hoek, R.A. Coutinho.
Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.
Am J Public Health, 84 (1994), pp. 275-281
[15.]
J. Castilla, G. Barrio, M.J. Belza, L. de la Fuente.
Drug and alcohol consumption and sexual risk behaviour among young adults: results from a national survey.
Drug Alcohol Depend, 56 (1999), pp. 47-53
[16.]
J.H. Samet, K.P. Mulvey, N. Zaremba, A. Plough.
HIV testing in substance abusers.
Am J Drug Alcohol Abuse, 25 (1999), pp. 269-280
[17.]
D. Whelan, M. Mahathir, H. Homans.
Report Gender and HIV/AIDS: Taking stock of research and programmes. Women, young people and infants.
UNAIDS/WHO, (1999),
[18.]
C. Dolezal, A. Ehrhardt, H. Meyer-Bahlburg, X. Liu, et al.
Sexual risk behaviour changes among HIV+ and HIV-female injecting drug users over 4 years.
Women Health, 27 (1998), pp. 1-17
[19.]
N. Pearce.
Traditional epidemiology, modern epidemiology and public heath.
Am J Public Health, 86 (1996), pp. 678-683
[20.]
L. de la Fuente, P. Lardelli, G. Barrio, J. Vicente, J.D. Luna.
Declining prevalence of injection as main route of administration among heroin users treated in Spain, 1991–1993.
Eur J Public Health, 7 (1997), pp. 421-426
Copyright © 2000. Sociedad Española de Salud Pública y Administración Sanitaria
